Insulin infusion therapy for myocardial infarction.

摘要: In the last 10 years, there has been considerable interest in administration of insulin as part management myocardial infarction. This review examines clinical trials infusion for infarction era reperfusion therapy, and discusses implications recently completed HI-5 (Hyperglycaemia: Intensive Insulin Infusion Infarction) study. The therapy can be divided into those with a primary aim delivering (insulin focus), achieving tight glycaemic control (glycaemia focus). evidence suggests that protocols an focus do not improve outcome However, glycaemia are inconclusive it remains possible is beneficial.